ERWINAZE

ERWINAZE (Asparaginase Erwinia Chrysanthemi)

ERWINAZE

Asparaginase Erwinia Chrysanthemi 

150mg Capsule

Eusa Pharma Incorporation

Medical Use

Erwinaze (asparaginase Erwinia chrysanthemi) is used to treat acute lymphoblastic leukemia (ALL) in patients who are allergic to E. coli-derived asparaginase. This cancer medication works by reducing the levels of asparagine, a substance necessary for cancer cell survival, thereby inhibiting the growth and spread of cancer cells.

Erwinaze is administered either as an intravenous infusion or an intramuscular injection and is typically part of a multi-agent chemotherapy regimen.